Tag: hydrogel
Instylla announces initial enrolment in prospective, multicentre HALT Study
Instylla has announced the enrolment of the first patient in the HALT study for the treatment of peripheral arterial bleeds. The HALT study is...
Instylla announces positive results from preclinical studies of Embrace hydrogel embolic...
Instylla, a company developing liquid embolics for peripheral vascular embolotherapy, recently announced two publications that evaluated the Embrace hydrogel embolic system (HES) in preclinical...
Interventional News’ top 10 most read articles of June 2022
Among the most popular pieces from last month are reports on papers delivered at the Society of Interventional Radiology (SIR) 2022 Annual Meeting (11–16...
Early study suggests a new, injectable gel may greatly reduce chronic...
An experimental formulation of a hydrogel injected into spinal discs proved safe and effective in substantially relieving chronic low back pain caused by degenerative...
Augmenix announces first prostate cancer patients treated with SpaceOAR hydrogel in...
Augmenix, a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy and interventional...
